Close Menu

NEW YORK – GenMark Diagnostics reported after the close of the market Wednesday that its third quarter revenues rose 32 percent year over year, driven by growth in ePlex molecular diagnostic analyzer placements.

For the three months ended Sept. 30, the firm reported revenues of $20.9 million, up from $15.8 million a year ago, and edging the consensus Wall Street estimate of $20.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.